BioStem Technologies (OTCMKTS:BSEM) Posts Earnings Results, Beats Expectations By $0.31 EPS

BioStem Technologies (OTCMKTS:BSEM) issued its quarterly earnings data on Monday. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.31, Zacks reports.

BioStem Technologies Stock Performance

BioStem Technologies stock traded down $0.02 during midday trading on Monday, hitting $12.89. 186,288 shares of the company’s stock were exchanged, compared to its average volume of 62,769. The stock has a 50-day moving average price of $11.86 and a two-hundred day moving average price of $13.72. BioStem Technologies has a 52-week low of $6.77 and a 52-week high of $28.26. The company has a market cap of $215.30 million, a P/E ratio of 18.96 and a beta of 0.09.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.